Improving Access to Antiretrovirals in China: Economic Analyses of Dolutegravir in HIV-1 Patients

Cost Effectiveness and Resource Allocation - United Kingdom
doi 10.1186/s12962-019-0195-2
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Mitochondrial Toxicity of Antiretrovirals in Non-Hiv-Infected Patients

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Genotypic Resistance Assay to Antiretrovirals in HIV-1 Infected Individuals

Juntendo Medical Journal
2004English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals During Pregnancy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients

PLoS ONE
Multidisciplinary
2019English

Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS

Infection and Drug Resistance
Infectious DiseasesPharmacology
2015English

Justice and HIV Care in Africa—Antiretrovirals in Perspective

Journal of the International Association of Physicians in AIDS Care
2002English

Is Improving Access to University Enough? Socio-Economic Gaps in the Earnings of English Graduates

Oxford Bulletin of Economics and Statistics
EconomicsProbabilityUncertaintyEconometricsStatisticsSocial Sciences
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy